Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hookipa Pharma Inc

0.7800
+0.03004.00%
Volume:4.29K
Turnover:3.50K
Market Cap:9.41M
PE:-0.22
High:0.8531
Open:0.7700
Low:0.7700
Close:0.7500
Loading ...

Poolbeg Pharma: Under Terms Poolbeg Shareholders to Receive 0.03 HOOKIPA Shares for Each Poolbeg Share Held

THOMSON REUTERS
·
02 Jan

RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk

MT Newswires Live
·
20 Dec 2024

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program

TipRanks
·
22 Nov 2024

Sector Update: Health Care Stocks Climb Thursday Afternoon

MT Newswires Live
·
22 Nov 2024

HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program

MT Newswires Live
·
21 Nov 2024

BRIEF-Hookipa Pharma Inc - On November 18 Approved Plan to Reduce Workforce By Approximately 80%

Reuters
·
21 Nov 2024

HOOKIPA Pharma - Restructuring Plan to Begin in Q4 2024, Complete by H1 2025

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma - to Pause Clinical Development in Eseba-Vec Program

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma - Early Termination of Hpv16+ Trial Not Due to Efficacy or Safety

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma Inc - on November 18, Co Approved a Planto Reduce Workforce by Approximately 80%

THOMSON REUTERS
·
21 Nov 2024

HOOKIPA Pharma Inc: Will Focus Primarily on Progressing the Phase 1-Ready Hb-700 Program for the Treatment of Kras Mutant Cancers

THOMSON REUTERS
·
21 Nov 2024

Analysts Are Bullish on These Healthcare Stocks: Hookipa Pharma (HOOK), Cue Biopharma (CUE)

TIPRANKS
·
18 Nov 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
17 Nov 2024

HOOKIPA Pharma Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

RBC Trims Price Target on HOOKIPA Pharma to $48 From $50, Keeps Outperform, Speculative Risk

MT Newswires Live
·
15 Nov 2024

U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart

Reuters
·
15 Nov 2024

HOOKIPA Pharma Q3 2024 GAAP EPS $(1.10) Beats $(1.28) Estimate, Sales $4.703M Miss $6.250M Estimate

Benzinga
·
15 Nov 2024

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

GlobeNewswire
·
15 Nov 2024

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker

GlobeNewswire
·
12 Nov 2024

Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and SCYNEXIS (SCYX)

TIPRANKS
·
12 Nov 2024